KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Total Debt (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.44%
Dec 31, 2025 -7.90%
Sep 30, 2025 -0.42%
Jun 30, 2025 -1.06%
Mar 31, 2025 0.12%
Dec 31, 2024 -0.21%
Sep 30, 2024 -5.03%
Jun 30, 2024 -5.91%
Mar 31, 2024 39.99%
Dec 31, 2023 5.77%
Sep 30, 2023 -0.19%
Jun 30, 2023 -0.41%
Mar 31, 2023 -3.79%
Dec 31, 2022 0.57%
Sep 30, 2022 -7.04%
Jun 30, 2022 -6.48%
Mar 31, 2022 0.94%
Dec 31, 2021 -0.42%
Sep 30, 2021 -0.92%
Jun 30, 2021 -2.43%
Mar 31, 2021 -8.67%
Dec 31, 2020 12.74%
Sep 30, 2020 -3.69%
Jun 30, 2020 -0.07%
Mar 31, 2020 -0.06%
Dec 31, 2019 87.24%
Sep 30, 2019 -0.08%
Jun 30, 2019 315.19%
Mar 31, 2019 -18.14%
Dec 31, 2018 0.57%
Sep 30, 2018 -1.08%
Jun 30, 2018 -4.06%
Mar 31, 2018 -3.29%
Dec 31, 2017 -5.70%
Sep 30, 2017 2.75%
Jun 30, 2017 -2.57%
Mar 31, 2017 25.73%
Dec 31, 2016 -1.73%
Sep 30, 2016 1.34%
Jun 30, 2016 0.55%
Mar 31, 2016 0.15%
Dec 31, 2015 -8.04%
Sep 30, 2015 -1.30%
Jun 30, 2015 -1.17%
Mar 31, 2015 -4.79%
Dec 31, 2014 2.14%
Sep 30, 2014 -0.89%
Jun 30, 2014 1.16%
Mar 31, 2014 -8.30%
Dec 31, 2013 15.64%
Sep 30, 2013 0.08%
Jun 30, 2013 -8.72%
Mar 31, 2013 6.76%
Dec 31, 2012 0.48%
Sep 30, 2012 35.15%
Jun 30, 2012 0.55%
Mar 31, 2012 -1.38%
Dec 31, 2011 -2.28%
Sep 30, 2011 1.81%
Jun 30, 2011 2.00%
Mar 31, 2011 -0.62%
Dec 31, 2009 -3.52%
Sep 30, 2009 3.68%